Julia Spencer | Associate Vice President, Global Vaccine Public Policy, Partnerships

Julia Spencer, Associate Vice President, Global Vaccine Public Policy, Partnerships, Merck

In 2017, Julia Spencer was appointed the Executive Director, Global Vaccines Public Policy, Partnerships, and Government Affairs at MSD. She leads global public policy and advocacy to expand access to Merck vaccines and develops and guides policy strategy and tactical implementation to achieve maximum population health impact and business growth. Julia brings to this role more than 25 years of public health and health policy experience at the local, state, national, and international levels. Julia joined MSD in 2014 as the lead for International Vaccines Public Policy. In this role, she oversaw the formation of a dedicated, internationally-focused policy team charged with strengthening partnerships and developing new platforms for evidence-based policy engagement on critical vaccines issues. Prior to joining MSD, Julia served for 15 years as a senior health official in the US Department of Health and Human Services (HHS). Her tenure at HHS included service as the Science Policy Director within the HHS Secretary’s policy, planning, and evaluation office (ASPE). She was responsible for policy coordination, planning, and legislative development focused on the HHS science agencies – Centers for Disease Control and Prevention, Food & Drug Administration, National Institutes of Health, and Office of the Assistant Secretary for Preparedness and Response. During the decade she worked in ASPE, she led the creation of two 5-year HHS Strategic Plans, the first HHS Global Health Strategy, and the Health System Measurement Project; developed a new HHS-wide evaluation capacity development initiative; and served as a senior policy analyst in the US CDC Rwanda Office. Prior to joining ASPE, she spent six years working on tobacco policy and substance abuse prevention efforts with HHS’s Substance Abuse and Mental Health Services Administration. Julia holds a Doctor of Philosophy degree in public health, Master of Science in Public Health, and Bachelor’s degrees in psychology and health education.


April 15 Plenary Congress Day 1 @ 09:45

How can we be better prepared for disease X?

  • What kind of regulatory and political support can we expect?
  • Prevention and pre-prepared efforts to ensure our current and future safety
  • Vaccine development and innovation including the current landscape, existing challenges, and drivers and levers to incentivize development

April 16 Day 2 - 10 Co-conferences @ 09:10

From development to deployment: Challenges and achievements in creating an Ebola vaccine

last published: 25/Mar/19 13:35 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071